Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Epista Life Science A/S
A/S
Active
Advertising protection
CVR 32141064
Slotsmarken 17, 2970
Hørsholm
Computer consultancy and computer facilities management activities
·
NACE 6220
Est. 2009 · 17 years old
92 employees
www.epista.com
Monitor
Share
Denmark
/
Companies
/
Computer consultancy and computer facilities management activities
/
Epista Life Science A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
130M
97M
65M
32M
0M
2021: 48M
48M
2021
2022: 47M (-2% vs 2021)
47M
-2%
2022
2023: 80M (+70% vs 2022)
80M
+70%
2023
2024: 81M (+1% vs 2023)
81M
+1%
2024
2025: 104M (+28% vs 2024)
104M
+28%
2025
EBITDA
DKK millions
16M
10M
4M
-2M
-8M
2021: 7M
7M
2021
2022: 1M (-86% vs 2021)
1M
-86%
2022
2023: 11M (+1000% vs 2022)
11M
+1000%
2023
2024: 2M (-82% vs 2023)
2M
-82%
2024
2025: -3M (-250% vs 2024)
-3M
-250%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
104.010
80.942
79.705
46.783
48.207
Staff expenses
-107.043
-78.537
-68.757
-45.621
-40.771
EBITDA
-3.034
2.220
10.755
1.163
7.436
Depreciation & amort.
-8.956
-1.629
-1.127
-87
-87
EBIT
-11.990
591
9.628
1.076
7.349
Net financials
-31.200
-12.946
2.841
3.832
3.338
Profit before tax
-43.190
-12.355
12.469
4.908
10.687
Tax
-2.849
103
1.972
185
1.581
Net profit
-40.341
-12.458
10.497
4.723
9.106
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
140.294
164.998
81.338
54.138
25.191
Equity
42.811
29.331
39.004
28.807
14.662
Long-term debt
1.153
104.686
1.811
0
0
Short-term debt
89.826
24.290
39.638
25.331
10.529
Total debt
90.979
128.976
41.449
25.331
10.529
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-2,9 %
This company
2021
2025
Equity ratio
30,5 %
This company
38,2 %
Market median
This company
Market median
20% below market
2021
2025
Return on equity
-94,2 %
This company
18,4 %
Market median
This company
Market median
612% below market
2021
2025
Net profit margin (of gross profit)
-38,8 %
This company
2021
2025
Asset turnover (of gross profit)
0,74×
This company
2021
2025
Debt / equity
2,28×
This company
0,62×
Market median
This company
Market median
268% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Epista Life Science A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
